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(SUDNA), and sudden unexplained death. 17, 18 In this study, we use the term "SUDNA" while recognizing that it is a heterogeneous group of disorders and does not define a specific syndrome. SUDNA accounts for up to 30% of sudden death in adults, and is especially common in children, adolescents and younger adults. SUDNA has been linked to ion channel mutations in up to 25% of cases, indicating that some deaths from SUDNA are the result of channelopathies. 17,18 Exertional, n † † 16 1 ‡ 0.001 *The family history in these cases included long QT syndrome (2) , premature sudden death from unknown causes in father (1), premature sudden death for generations with unknown cause (1) . **The family history consisted of premature sudden death in mother (1), brother (1) , and father (1), all of unknown cause. † Collapse seen by others at home (28) , workplace (8) , in vehicle (1), other (2) . † † Basketball (9), running (5), soccer (1), swimming (1). ‡ Weightlifting. We speculated that mutations in PKP2 could also be associated with arrhythmias in the absence of the fibrofatty change of ARVC, and may occur in cases of SUDNA. In fact, we observed severe PKP2 mutations with the same frequency in ARVC and SUDNA cases.
Methods

Study Subjects
We studied 25 cases of sudden cardiac death with the diagnosis of ARVC and 25 cases of SUDNA from a single medical examiner's office and consulted by a cardiovascular pathologist. The study was approved by the institutional review board. All cases were seen in consultation by the cardiovascular pathologist and forensic pathologist and examined in a similar fashion.
Genotyping and Sequence Alignment
Genomic DNA was extracted from postmortem heart tissue using Qiagen ® kit. 19-21 All coding exons and flanking intronic sequences of PKP2 variant 2b (NM_004572.3) were amplified by polymerase chain reaction (PCR). Primers and PCR conditions are available on request. The primers were designed using the Primer Express 3.0 software. Direct sequencing for both sense and antisense strands was performed with a BigDye Terminator DNA sequencing kit on a 3130XL Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA). Data was analyzed with Lasergene software for identification of mutations (DNASTAR, Madison, WI, USA); 96 control DNA samples were studied for mutations found in the test samples. Mutation damage prediction was made using Mutation Taster software (http://www.mutationtaster.org), PolyPhen (http:// genetics.bwh.harvard.edu/pph2) and Sorting Intolerant from Tolerant (SIFT; http://sift.jcvi.org). Mutations were classified into 2 categories: (1) benign mutation, or missense mutation that was predicted to be benign or possibly damaging by one or more of the 3 bioinformatics analyses; and (2) pathogenic mutations, or nonsense, indels or missense mutations predicted to be probably damaging by all 3 bioinformatics analyses.
Statistical Analysis
The χ2 test was used to compare the frequency of mutations between the ARVC and SUDNA groups. A P value <0.05 was considered statistically significant.
Results
Clinicopathologic Characteristics
The age, sex, and pathologic findings related to the subjects are presented in Tables 1 and 2 .
Mutation Analysis of PKP2 in ARVC Samples
We identified 6 unique genetic variants in PKP2 in 6 of the 26 ARVC cases. In 1 case there were 2 distinct PKP2 mutations and in 2 non-related cases there was the same D26N change that was considered a benign polymorphism in previous studies.22,23 The 6 different mutations comprised 3 missense substitutions, 1 nonsense substitution, 1 deletion and 1 insertion (Figure 1) . Details regarding the identified mutations are summarized in Table 3 . The missense substitutions were 805G>A (G269R), 76G>A (D26N) and 2062T>C (S688P). S688P has been described previously and was predicted to be damaging by all 3 bioinformatics analyses (PolyPhen, SIFT and Mutation Taster). G269R was predicted to be benign by PolyPhen, SIFT and Mutation Taster. The deleterious nonsense substitution was c.1951C>T (R651X), and has already been described. 22 The inframe deletion c.1925-1927ACA del (N641del), and frameshift c.187_188insC (L64P fsX22) insertion were novel. In summary, of the 6 mutations found, 4 are pathogenic, and 2 are probably benign polymorphisms. None of the mutations was identified in 96 normal controls.
The mean age of patients with pathogenic mutations was 36 years in the ARVC group, and 28 in the SUDNA group (P=0.3).
Mutation Analysis of PKP2 in SUDNA Samples
In the 25 SUDNA cases, we identified 6 different heterozygous mutations in 6 cases (24%). None of these mutations was present in the 96 normal controls; 4 were novel and 5 were missense mutations: 1016T>C (F339S), 1592T>G (I531S), 1618G>A (E540K), 1843T>A (S615T) and 1993C>T (P665S). I531S was considered a benign polymorphism in previous 
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reports, given its presence in normal controls. 24, 25 All three bioinformatics analyses predicted E540K to be probably damaging, as well as S615T. A mutation in the same amino acid (S615F) has been described previously and was also considered pathogenic. 8,12 F339S and P665S were considered to be possibly damaging by PolyPhen, and to be benign by SIFT and Mutation Taster. We also detected a deletion with frameshift, 648_ 651delATAC (Y217T fsX45) (Figure 2) , which was novel. Details regarding the identified mutations are summarized in Table 4 . Table 3 . 
Correlation of Bioinformatics Analysis
Each group was classified into 3 categories: (1) negative (no mutation); (2) positive for benign mutation; or (3) positive for pathogenic mutation. No statistically significant differences in mutation frequencies between the ARVC and SUDNA cases were detected (P=0.842) ( Table 5) .
Discussion
Cellular adhesion plays a crucial role in the development and maintenance of multicellular tissues and organs of higher eukaryotes. The desmosome (macula adherens) is the morphologically most conspicuous cellular adhesion structure, and is particularly abundant in tissues such as epidermis and myocardium that are continually assailed by mechanical forces. Desmosomes contain members of at least 3 protein families. Desmosomal cadherins form the intercellular adhesive interface, whereas armadillo and plakin family proteins build up the plaques. It is believed that the cytoplasmic tail of desmogleins (Dsgs) and desmocollins (Dscs) interact with plakoglobin, which in turn binds to desmoplakin. Desmoplakin finally is anchored to the intermediate filament cytoskeleton. 26 These interactions seem to be stabilized laterally by plakophilin. 27 Recent evidence indicates that mutations in several desmosomal components play a major role in the pathogenesis of ARVC. 7,8,10-14 Among the genes in which mutations associated with ARVC have been identified, plakophilin-2 accounts for a large proportion. Plakophilins are a family of armadillo-repeatcontaining proteins that share a high degree of sequence similarity with the adherens junction component, p120. However, these armadillo-repeat proteins localize to the desmosomal plaque and the nucleus in many epithelial tissues. 27 Three members (PKP 1-3, and occasionally p0071, or plakophilin 4) have been characterized and constitute an individual subfamily of armadillo-repeat proteins. 28 Although plakophilins are widely expressed in many epithelial tissues and likely perform redundant roles in these tissues, PKP-2 is the sole member of this family expressed in cardiomyocytes. 29 PKP2 encodes 2 isoforms, the longer (PKP2b) includes the alternatively spliced exon 6, while the shorter (PKP2a) does not include the sequence encoded by exon 6. Recently, Gandjbakhch et al. found PKP2a was shown to be the major isoform expressed in human heart tissue and PKP2b protein was undetectable. 30 PKP 2 interacts with desmoplakin, plakoglobin, Dsg 1 and 2, and Dsc 1a and 2a, with the head domain apparently being critical for the assembly and maintenance of desmosomes. 31 In addition, PKP 2 is capable of associating with β-catenin, thereby regulating its signaling activity. Grossmann et al 29 studied the functional aspects of PKP 2 in a mouse gene knockout model. Homozygous ablation of PKP2 led to embryonic lethality at midgestation (E10.5-E11) because of aberrations in the architecture and function of the heart, as seen by reduced trabeculation, rupture of cardiac walls, and blood leakage into the pericardial cavity. In contrast, other tissues, in particular epithelia, seemed to be unaffected. Hence, PKP 2 is considered to be an essential morphogenetic and architectural component of the heart. Hall et al analyzed desmosome assembly and stability in epithelial cell lines expressing mutants of plakophilin-2 found in ARVC patients, and found that mutant plakophilin-2 is unable to initiate desmosome assembly. 32 The aforementioned studies have emphasized the structural instability of the cardiomyocyte junction that precedes the fibrous changes in ARVC and that results from mutations. Recently, Oxford et al used RNA silencing technology to decrease the expression of PKP2 in cardiac cells obtained from neonatal rat hearts, and found loss of PKP2 expression, a decrease in the total Cx43 content, and a significant redistribution of Cx43 to the intracellular space. 33 A significant reduction in Cx43 content is necessary to modify conduction velocity and may therefore directly contribute to arrhythmogenesis. 34 Furthermore, Sato et al demonstrated that PKP2 associates with voltage-gated sodium channel NaV1.5, and that knockdown of PKP2 expression alters the properties of the sodium current, and the velocity of action potential propagation in cultured cardiomyocytes. 35 These findings suggest that alterations in PKP2 and desmosome structure may be directly associated with arrhythmogenic potential.
The current study demonstrated that mutations in PKP2 may occur in cases of SUDNA, specifically in patients without evidence of fibrofatty change. SUDNA accounts for up to 30% of sudden death in adults, 16-18 and has been linked to ion channel mutations in a subset of cases, but so far not to desmosomal mutations. The current study demonstrated that PKP2 mutations are equally frequent in SUDNA as in ARVC, suggesting that they are not specific for ARVC, and that there may be a general effect on arrhythmogenicity as opposed to the fibrofatty changes characteristic of ARVC. The current study also highlights the rate of exertional deaths among patients with ARVC, which has been described previously. 6, 36 Although the current study does not suggest that PKP2 mutations predispose to exertional deaths, the sample size is too small to predict if PKP2-related deaths in the absence of ARVC are more or less likely to occur during exercise.
In the current study, the mean of the ARVC patients was significantly greater than that of the SUDNA group, and the mean age of the ARVC patients with potentially lethal mutations was older, although not significantly, than that of patients with SUDNA with mutations. There are several limitations to the current study. First, the small sample size precluded an accurate assessment of the overall rate of PKP2 mutations in ARVC or SUDNA cases. Furthermore, there is the possibility that the SUDNA patients with PKP2 mutations may subsequently develop histologic manifestations of ARVC, or that the SUDNA patients in the current study would have developed ARVC if they had not succumbed from their arrhythmia. This is unlikely because inflammatory and fibrous lesions are believed to be arrhythmogenic in themselves, regardless of etiology, and reactive fibro-inflammatory change secondary to desmosomal mutations has not been definitively established. Even if the SUDNA patients with PKP2 mutations were preclinical ARVC, it would suggest that the PKP2 protein defect in itself is arrhythmogenic, and not the fibrofatty change that pathologically defines ARVC. The apparent disconnect between the fibrofatty foci in ARVC and the mutations in desmosomal proteins needs to be further studied, as well as the incidence of desmosomal mutations in sudden death related to other morphologic findings, such as coronary artery disease and hypertrophic cardiomyopathy for example.
In conclusion, our results demonstrate that PKP2 mutations are similar in incidence and significance in ARVC as well as SUDNA. These findings suggest a link between the desmosome and arrhythmias in the absence of the fibrofatty change characteristic of ARVC. Hence, desmosomal mutations may not in themselves cause fibrofatty change and the syndrome of ARVC. It seems unlikely that the SUDNA cases in the current study represent an early stage of ARVC, as the precursor of fibrofatty change in ARVC has been postulated to be linked to inflammation and previous episodes of myocarditis, 37,38 which were not evident in these cases. More studies of PKP2 genotype are necessary in populations other than
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ARVC in order to definitively establish a link between ARVC and the desmosome.
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